Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - hydrocortisone, quantity: 10 mg/ml; ciprofloxacin, quantity: 2 mg/ml - ear drops, suspension - excipient ingredients: polysorbate 20; sodium acetate; glacial acetic acid; benzyl alcohol; hydrogenated soy phosphatidylcholine; sodium chloride; polyvinyl alcohol; purified water - for the treatment of acute bacterial otitis externa, caused by organisms susceptible to ciprofloxacin (see pharmacology), in adults and children aged 2 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - ear drops, solution - excipient ingredients: purified water; sodium acetate; mannitol; hydrochloric acid; glacial acetic acid; benzalkonium chloride; disodium edetate; sodium hydroxide - treatment of chronic suppurative otitis media caused by organisms susceptible to ciprofloxacin in adults and children one month of age or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - ear drops, solution - excipient ingredients: mannitol; purified water; benzalkonium chloride; sodium hydroxide; disodium edetate; sodium acetate; hydrochloric acid; glacial acetic acid - treatment of chronic suppurative otitis media caused by organisms susceptible to ciprofloxacin in adults and children one month of age or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nystatin, quantity: 90000 u/ml; triamcinolone acetonide, quantity: 0.9 mg/ml; gramicidin, quantity: 0.225 mg/ml; neomycin sulfate (equivalent: neomycin, qty 2.25 mg/ml) - ear drops, solution - excipient ingredients: polyethylene; liquid paraffin - treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nystatin, quantity: 90000 u/ml; triamcinolone acetonide, quantity: 0.9 mg/ml; gramicidin, quantity: 0.225 mg/ml; neomycin sulfate (equivalent: neomycin, qty 2.25 mg/ml) - ear drops, solution - excipient ingredients: polyethylene; liquid paraffin - otocomb otic is indicated for the treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - marbofloxacin; clotrimazole; dexamethasone acetate - ear drops, suspension - 3, 10, 1 milligram(s)/millilitre - dexamethasone and antiinfectives - dogs - not currently available

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - dexamethasone; ciprofloxacin hydrochloride - ear drops - 1mg/1ml ; 3mg/1ml

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - ciprofloxacin - ear drops, solution - ciprofloxacin 3 mg/ml - otologicals

Malta - English - Medicines Authority

biocodex 7 avenue gallieni- 94250 gentilly, france - phenazone, lidocaine hydrochloride - ear drops, solution - lidocaine hydrochloride 1 % (w/w) phenazone 4 % (w/w) - otologicals

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - ciprofloxacin hydrochloride - ear drops, solution - 3 milligram(s)/millilitre - antiinfectives; ciprofloxacin